Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Faes Farma SA (FAE.MC) | XMAD | ES | 2024-12-31 | 1 week ago | EUR | 4.02 | 4.05 | 100.82% | 0.66 | 16.51% | Enterprising | 2.74 | 68.20% |
| 2 | Laboratorio Reig Jofre SA (RJF.MC) | XMAD | ES | 2024-12-31 | 1 week ago | EUR | 2.86 | 2.65 | 92.57% | 0.23 | 8.21% | Enterprising | 1.60 | 56.10% |
| 3 | Azkoyen SA (AZK.MC) | XMAD | ES | 2024-12-31 | 1 week ago | EUR | 7.46 | 8.99 | 120.50% | 0.68 | 9.15% | Enterprising | 4.15 | 55.65% |
| 4 | Viscofan SA (VIS.MC) | XMAD | ES | 2024-12-31 | 1 week ago | EUR | 67.20 | 37.31 | 55.51% | 6.37 | 9.48% | Enterprising | 28.14 | 41.87% |
| 5 | Axon Partners Group SA (APG.MC) | XMAD | ES | 2023-12-31 | 1 week ago | EUR | 15.50 | 8.34 | 53.78% | 0.92 | 5.91% | Enterprising | 6.04 | 38.97% |
| 6 | Laboratorios Farmaceuticos ROVI SA (ROVI.MC) | XMAD | ES | 2024-12-31 | 1 week ago | EUR | 49.60 | 28.37 | 57.20% | 4.49 | 9.05% | Enterprising | 18.36 | 37.01% |
| 7 | Inversiones Doalca SOCIMI SA (YDOA.MC) | XMAD | ES | 2024-12-31 | 2 weeks ago | EUR | 25.20 | 12.77 | 50.66% | 0.33 | 1.30% | Enterprising | 8.74 | 34.70% |
| 8 | Tier 1 Technology SA (TR1.MC) | XMAD | ES | 2023-12-31 | 3 months ago | EUR | 3.00 | 1.37 | 45.72% | 0.32 | 10.69% | Enterprising | 0.94 | 31.22% |
| 9 | Singular People SA (SNG.MC) | XMAD | ES | 2023-12-31 | 1 week ago | EUR | 1.99 | 1.67 | 84.16% | 0.13 | 6.63% | Enterprising | 0.59 | 29.85% |
| 10 | General de Galerias Comerciales SOCIMI SA (YGGC.MC) | XMAD | ES | 2021-12-31 | 2 years ago | EUR | 141.00 | 49.52 | 35.12% | 6.16 | 4.37% | Enterprising | 34.10 | 24.19% |